He is the primary inventor of over 15 patents and holds a BS in Neuroscience & Cell Biology from Rutgers University and MS in Computer Science from the New York University
During his academic career, Sam co-authored various longevity research publications including DrugAge, a database of anti-aging drugs. He conducted his PhD research at the FSU Jena and the Leibniz Institute on Aging.
He is a pioneer in the field of genome sequencing and gene editing and received many awards for his work including the 2011 Bower Award and Prize for Achievement in Science from the Franklin Institute and election to the National Academy of Sciences and Engineering. George has co-founded over 50 biotech companies.
Jan is an expert in genome instability and somatic mutations and has received numerous rewards for is his work including the Nathan Shock New Investigator Award of The Gerontological Society of America (1994) and the Irving Wright Award of Distinction of the American Federation for Aging Research (2012)
Alex devotes most of his time to developing new approaches to the identification of somatic mutations of various types. Moreover, he developed a novel next-generation sequencing-based approach for genome-wide assessment of somatic mutational load in normal cells and tissue.
Claudia has over 30 years of experience in tumor immunology and conducted research in various word class institutes including Erasmus University in Rotterdam, Harvard Medical School, and the California Pacific Medical Center Research Institute. She has published 76 scientific articles, is a reviewer for various scientific journals, and served as a reviewer on several NIH/DOD/PCAN study sections.
Eric scales teams with the patient always being top of mind. He also leans strategically on his legal background, giving him a unique vantage point when operating within highly regulated spaces.